Pancreatic Cancer Research

ResearcherMustafa Kemal UniversityNo recent work listed

İsa Dede

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1836-9370; OpenAlex author ID A5091450173. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper

Papers 2

  1. Prognostic value of the neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 in estimating survival in patients with metastatic pancreatic cancer. First author DOI 10.4103/jcrt.jcrt_366_19↗
  2. Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospective analysis. Co-author PMID 30722120↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Şirin Çetin · 1 shared paper, 2020 · strength 0.24
  2. Nebi Serkan Demirci · 1 shared paper, 2018 · strength 0.07
  3. Hüseyin Engin · 1 shared paper, 2018 · strength 0.07
  4. Nurullah Zengin · 1 shared paper, 2018 · strength 0.07
  5. Elif Berna Köksoy · 1 shared paper, 2018 · strength 0.07
  6. Yüksel Ürün · 1 shared paper, 2018 · strength 0.07
  7. Nuriye Özdemir · 1 shared paper, 2018 · strength 0.07
  8. Yakup Ergün · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.